Lineage Cell Therapeutics, Inc. (LCTX)
0.82
-0.02
(-2.21%)
USD |
NYAM |
Nov 19, 16:00
0.841
+0.02
(+2.56%)
After-Hours: 07:41
Lineage Cell Therapeutics Total Assets (Quarterly) : 100.11M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 100.11M |
| June 30, 2026 | 106.22M |
| March 31, 2026 | 109.53M |
| December 31, 2025 | 112.58M |
| September 30, 2025 | 89.64M |
| June 30, 2025 | 90.80M |
| March 31, 2025 | 111.75M |
| December 31, 2024 | 113.22M |
| September 30, 2024 | 96.59M |
| June 30, 2024 | 102.80M |
| March 31, 2024 | 108.48M |
| December 31, 2023 | 101.02M |
| September 30, 2023 | 106.15M |
| June 30, 2023 | 111.69M |
| March 31, 2023 | 113.20M |
| December 31, 2022 | 123.66M |
| September 30, 2022 | 131.15M |
| June 30, 2022 | 135.92M |
| March 31, 2022 | 144.52M |
| December 31, 2021 | 174.54M |
| September 30, 2021 | 131.21M |
| June 30, 2021 | 134.75M |
| March 31, 2021 | 127.93M |
| December 31, 2020 | 107.95M |
| September 30, 2020 | 103.09M |
| Date | Value |
|---|---|
| June 30, 2020 | 112.08M |
| March 31, 2020 | 118.88M |
| December 31, 2019 | 125.48M |
| September 30, 2019 | 132.98M |
| June 30, 2019 | 151.69M |
| March 31, 2019 | 183.72M |
| December 31, 2018 | 101.66M |
| September 30, 2018 | 176.08M |
| June 30, 2018 | 112.25M |
| March 31, 2018 | 110.40M |
| December 31, 2017 | 173.24M |
| September 30, 2017 | 221.87M |
| June 30, 2017 | 193.35M |
| March 31, 2017 | 205.22M |
| December 31, 2016 | 142.57M |
| September 30, 2016 | 147.57M |
| June 30, 2016 | 104.33M |
| March 31, 2016 | 80.11M |
| December 31, 2015 | 94.66M |
| September 30, 2015 | 76.86M |
| June 30, 2015 | 79.61M |
| March 31, 2015 | 69.70M |
| December 31, 2014 | 74.90M |
| September 30, 2014 | 55.65M |
| June 30, 2014 | 65.99M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Curis, Inc. | 18.80M |
| Armata Pharmaceuticals, Inc. | 84.48M |
| Voyager Therapeutics, Inc. | 177.05M |
| Black Diamond Therapeutics, Inc. | 115.56M |
| Invivyd, Inc. | 183.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 34.17M |
| Shareholders Equity (Quarterly) | 67.06M |
| Debt to Equity Ratio | 0.0303 |
| Current Ratio | 5.958 |
| Net Debt Paydown Yield | 0.01% |